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Abstract 
Aim: Little is known about inpatient probiotic and prebiotic consumption or beliefs, 
despite their increase in availability. Therefore, the purpose of this research was 
to assess inpatient knowledge, use and perceptions of probiotics and prebiotics. 
Methods: All subjects were inpatients at two urban medical centers on general 
medical/surgical floors. Patients were randomly selected to complete a verbally 
administered questionnaire inquiring about probiotic and prebiotic knowledge, 
use and perceptions. Patient responses were recorded directly into Survey Mon-
key (Palo Alto, CA, USA) on a computer. 
Results: Patients (n = 200) were 58% were women and 56% were Caucasian with a 
mean age of 56 years. More patients were familiar with the term “probiotic” (43%) 
compared with “prebiotic” (11%); however, only 20% and 7% could correctly define 
probiotics and prebiotics, respectively, from a list of responses. More patients were 
consuming probiotics (53%) than prebiotics (38%). The most common probiotic 
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and prebiotic products consumed were yogurts (72%) and cereals/granola bars 
(55%), respectively. Patients believed probiotics and prebiotics most beneficial for 
“digestion or gut health”, but the most common reason to consume these prod-
ucts was “to taste or try” (36% and 43%, respectively). Overall, patients believed 
probiotics and prebiotics to be safe; however, they also believed that health claims 
could only somewhat be trusted. 
Conclusions: This research found that many patients are consuming probiotic and 
prebiotic products despite limited awareness of the true meaning of these terms. 
As probiotic and prebiotic use is more common, it is important that clinicians are 
aware of increased use and provide patients with recommendations based on re-
cent research. 
Keywords: clinical nutrition and dietetics, clinical trials, consumers, dietary intake, 
food preferences, health beliefs
Introduction 
The human gastrointestinal tract is home to trillions of bacteria that have a 
symbiotic relationship with the host. These bacteria have many important 
functions including immunity, harvesting energy and altering lipid metabo-
lism. Recognition of these important functions has resulted in development 
of commercial products that include probiotics and prebiotics. These prod-
ucts are intended to modify gut bacteria to benefit host health.1 
A probiotic is a live microorganism that, when administered in adequate 
amounts, confers a health benefit on the host.2 Probiotics have been recog-
nized as helpful for health for over 100 years; Élie Metchnikoff received the 
Nobel Prize in Medicine in 1908 for his work with gut microbiota and im-
mune system. Yakult (Yakult Honsha Co., Ltd) is a Japanese dairy probiotic 
product on the market since 1935. Despite being in existence and recog-
nized for health promotion for over 100 years, probiotics have only recently 
become popular, with commercially available probiotics such as Yakult and 
Activia (Dannon). The global market for probiotic products is estimated to 
be 26 million in 2012 and the market increased by approximately $1.5 bil-
lion in a 5-year period.3 A prebiotic is a selectively fermented ingredient that 
allows specific changes, both in the composition and/or activity in the gas-
trointestinal microflora that confer benefits upon host wellbeing and health.4 
These prebiotic  fibers, commonly inulin and fructooligosaccharides (FSO), 
are fermented in the intestine, so as to stimulate growth of beneficial bac-
teria already in the gut.4 
Recent research has examined the effects of probiotics and prebiotics 
for alleviation of various health conditions. Overall, current research sug-
gests a positive effect of probiotics and prebiotics in gastrointestinal transit 
time, irritable bowel syndrome and ulcerative colitis.5–19 Much research has 
shown a benefit of probiotics in antibiotic-associated diarrhoea.20–23 However, 
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a recent large randomized controlled trial showed no benefit of probiotic 
supplementation in incidence of antibiotic-associated diarrhoea.24 Clarifica-
tion is needed to determine what dose and which strains are beneficial for 
different health conditions. 
Although a substantial increase in consumption of probiotic- and prebi-
otic-containing products has been seen in the last decade, the current con-
sumer knowledge, use and perceptions of these products has not been ex-
amined. Therefore, the purpose of the present research was to gain a better 
understanding of how many, which types, and for what purpose hospital pa-
tients are taking probiotic and prebiotic products, and to compare differ-
ences based on patient demographics. 
Methods 
This was a descriptive, cross-sectional study designed to describe the knowl-
edge, use and perceptions of probiotics and prebiotics of patients at two 
large urban hospitals in Chicago. Inclusion criteria were adults aged 18 years 
and over, admitted to the hospital within the previous 72 hours and those 
who were oriented to person, place and time. Subjects were excluded from 
the study if they could not speak or understand English, were located on 
the pediatric, psychiatric, obstetrics/gynecology, oncology or intensive care 
unit floors, had contact or airborne precautions, or did not give their con-
sent. Ethical approval from the Institutional Review Boards at Rush Univer-
sity Medical Center and Christ Advocate Medical Center was obtained before 
study initiation and conforms to the provisions of the Declaration of Helsinki. 
The questionnaire used in this study was developed without modelling 
from any previously developed tool. The tool was created to quantitatively 
and qualitatively measure probiotic and prebiotic knowledge use and per-
ceptions. Ten pilot interviews were performed with nutrition experts to eval-
uate the content, flow and ease of administering the questionnaire. An addi-
tional 10 pilot interviews were completed with patients; as no changes were 
made to the questionnaire after these pilot interviews, the pilot interviews 
were included in the final sample. 
The questionnaire consisted of 18 questions; questions addressing 
knowledge of probiotic and prebiotic terms and concepts were asked first. 
Only patients familiar with the concept of probiotics or prebiotics answered 
questions about perceptions. Additional questions included beliefs regard-
ing probiotic and prebiotics benefit to health conditions, current or past 
consumption, and reasons for consuming these products. Questions ad-
dressing influences on use and perceptions regarding safety were included. 
All questions had corresponding handouts with examples of health condi-
tions, probiotic and prebiotic products, and a rating scale (1 = not at all; 2 
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= a little; 3 = somewhat; 4 = quite a bit; 5 = very much) as a guide for pa-
tient response. Probiotic and prebiotic products were chosen for handouts 
based on products researchers believed to be most accessible to consum-
ers and most commonly consumed. In addition, demographic information 
was obtained. 
Eligible patient units and patients within each unit were randomized 
using a random numbers table. A maximum of seven questionnaires were 
completed each data collection day. Enough patients were approached to 
obtain 100 completed questionnaires at each hospital. After a patient was 
randomly chosen, the patient was approached, a cognitive assessment was 
completed, and the patient was provided a letter of introduction. Two study 
coordinators performed all interviews and directly recorded answers into 
Survey Monkey. After the interview was completed, patients were offered a 
handout with information about probiotics and prebiotics as well as exam-
ples of products. Patients were not told about this information prior to the 
interview to avoid response bias. 
The Statistical Package for the Social Sciences (SPSS) Version 17.0 (SPSS, 
Inc., Chicago, IL, USA) was used for data analysis. Descriptive statistics were 
run for all items; means, standard errors and frequencies were calculated 
to describe distributions and differences in knowledge and use of probiot-
ics and prebiotics. Differences across gender, age, race and education level 
were analyzed with chi-squared analysis. Data were normally distributed; 
therefore, analysis of variance was used to assess differences across demo-
graphic characteristics and variables for which a mean could be calculated. 
Results 
Of the 300 patients that were asked to complete the survey, 100 declined 
to participate. A total of 200 patients completed the study (67% response). 
Women comprised 58% of the sample, the mean age of participants was 56 
years, and a majority of patients were Caucasian (56%). Most patients (46%) 
had completed 12 or less years of education, 43% had completed 13–16 
years and 12% had completed 17 or more years. 
When patients were asked if they were familiar with the term “probiotic” 
or “prebiotic”, 43% and 11% of patients were familiar with the terms, respec-
tively. From a selection of five definitions, 20% of patients who stated they 
were familiar with the term chose the correct definition: “probiotics are live 
bacteria that are helpful to your health when you eat them.” Incorrect def-
initions of the term “probiotic” offered to patients included natural antibi-
otics, fibers to help feed good bacteria, cleaning products to kill bacteria 
and agents to make food taste sweeter. A total of 7% of patients chose the 
correct definition of a prebiotic: “prebiotics are foods that you eat that help 
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feed the good bacteria in your body.” Incorrect definitions of the term “pre-
biotic” offered to patients included live bacteria helpful to health, a type of 
vitamin, drugs to help lower blood pressure and harmful chemicals. After 
these, correct definitions were briefly explained; 73% and 52% of the origi-
nal 200 patients were familiar with the concepts of probiotics and prebiot-
ics, respectively. 
Patients with more years of education were more likely to be familiar with 
the term “probiotic” (P < 0.000) than those with less education. Patients who 
were younger than 45 years of age (P = 0.011), and who had more educa-
tion (P = 0.001) were more likely to be familiar with the probiotic concept 
compared with those older than 45 years of age, or with less education. No 
significant differences in knowledge of the prebiotic term or concept were 
found based on demographic characteristics. 
Patient perceptions of probiotics and prebiotics are shown in Table 1. 
Overall, patients did not believe that probiotics or prebiotics were harmful, 
as evidenced by 90% of patients responding with “not at all” or “a little” to 
the statement “probiotics are harmful.” The majority (95% of patients) chose 
these responses for prebiotics. Patients aged less than 45 years believed pro-
biotics and prebiotics to be safer than other age groups (P = 0.039). 
Table 1. Perceptions of probiotics and prebiotics grouped by medical center patient demographics.(a)
                                                                                                     Mean ± SD(b,c)
 Probiotics are Probiotics are Health claims  Prebiotics are Prebiotics are Health claims
 harmful safer than on probiotic  harmful safer than  on prebiotic 
  prescription  packages can  prescription  packages can 
  drugs be trusted  drugs be trusted
Overall  1.27 ±± 0.64  3.29 ± 1.35  2.95 ± 1.10  1.20 ± 0.52  3.29 ± 1.34  3.14 ± 1.08
Gender
    Female  1.25 ± 0.62  3.40 ± 1.37  3.10 ± 1.18  1.24 ± 0.55  3.31 ± 1.34  3.21 ± 1.07
    Male  1.30 ± 0.66  3.14 ± 1.32  2.75 ± 0.98  1.14 ± 0.47  3.26 ± 1.35  3.02 ± 1.08
Age group (years)
    45  1.15 ± 0.52x  3.76 ± 1.14x  3.11 ± 0.99x  1.12 ± 0.4x  3.55 ± 1.23x  3.21 ± 1.19
    45–65  1.23 ± 0.60  3.13 ± 1.40y  3.15 ± 1.13x  1.09 ± 0.3x  3.43 ± 1.38x  3.30 ± 1.04
    65 1.49 ± 0.76y  2.97 ± 1.39y  2.44 ± 1.05y  1.47 ± 0.7y  2.80 ± 1.27y  2.79 ± 0.94
Education (years)
    ≤ 12  1.46 ± 0.78x  3.04 ± 1.43  2.88 ± 1.12  1.28 ± 0.62  3.30 ± 1.41  3.15 ± 1.17
    13–16  1.12 ± 0.45y  3.61 ± 1.14  2.96 ± 1.11  1.17 ± 0.48  3.33 ± 1.19  3.06 ± 1.00
    ≥ 17  1.26 ± 0.62  2.96 ± 1.55  3.09 ± 1.08  1.07 ± 0.52  3.13 ± 1.60  3.33 ± 1.05
(a) Based on total number of subjects who responded knowing probiotic (n = 146) or prebiotic concept (n = 103).
(b) Scale: 1 = not at all; 2 = a little; 3 = somewhat; 4 = quite a bit; 5 = very much.
(c) Different letters signify significant differences within demographic: P < 0.05 using analysis of variance.
SD, standard deviation.
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A majority of patients identified both probiotics and prebiotics as bene-
fiting gastrointestinal health (Table 2), with the greatest benefit believed to 
be for both constipation and diarrhea (greater than 87% and 78% believed 
probiotics and prebiotics benefit these conditions, respectively). This is likely 
because the majority of advertising for these products is targeted for gas-
trointestinal health. Use of probiotics and prebiotics for both immune and 
heart health were also perceived as beneficial. 
Table 2. Health conditions for which patients believe probiotics and prebiotics are ben-
eficial and for which patients consume probiotics and prebiotics.
        Believed
       beneficial          Consumed
Health condition  n(a)  %(b)  n(a)  %(c)
Probiotics
   Constipation  56  89  14  25
   Diarrhoea  55  87  5  9
   Overall digestion/gut health  54  86  23  41
   Immune health  43  68  6  11
   Heart health  38  60  0  0
   Overweight/obesity  42  67  3  5
   Allergies  35  56  0  0
   Mental health/stress  27  43  0  0
   To taste/to try(d)  –  –  19  34
Prebiotics
   Constipation  22  79  6  18
   Diarrhoea  22  79  0  0
   Overall digestion/gut health  21  75  7  21
   Immune health  20  71  6  18
   Heart health  20  71  2  6
   Overweight/obesity  15  54  13  39
   Allergies  13  46  0  0
   Mental health/stress  16  57  0  0
   To taste/to try  –  –  13  39
(a) Total number of subjects who indicated probiotics or prebiotics to be helpful for a spe-
cific condition or consumed for a condition.
(b) Based on total subjects who responded knowing probiotic (n = 63) or prebiotic (n = 28) 
concept; percentage total is greater than 100 because subjects could choose more than 
one answer.
(c) Based on total subjects who consumed probiotics (n = 56) or prebiotics (n = 33); per-
centage total is greater than 100 because subjects could choose more than one answer.
(d) To taste/to try was not included when asked for which health conditions probiotics and 
prebiotics are beneficial.
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Consumption of probiotics and prebiotics for specific health conditions 
was also assessed (Table 2). Similar to what was believed beneficial, patients 
were most likely to consume probiotics for digestion and gut health, includ-
ing constipation (25%). On the contrary, patients consumed prebiotics for 
overweight/obesity and to taste or try. 
Health conditions patients believed were most improved by probiotics 
as indicated on the 5-point scale handout included immune health (3.70 ± 
0.99) and digestion/gut health (3.08 ± 1.28). Overall, 34% of patients be-
lieved probiotics helped their health “quite a bit” or “very much.” Health con-
ditions patients believed were most improved by prebiotics included general 
health (4.00 ± 0.00), digestion/gut health (3.78 ± 1.26) and immune health 
(3.31 ± 1.11). Overall, 33% believed prebiotics helped their health “quite a 
bit” or “very much.” It was noted during data collection that many patients 
stated they were consuming prebiotics for the benefits of fiber, and not 
the prebiotic properties these products provide. Many patients mentioned 
their belief that if they had consumed both probiotic and prebiotic products 
more regularly, they would have seen more health benefits, although this 
question was not asked formally as part of the survey and was only men-
tioned by patients during data collection. Therefore, many may have cho-
sen a lower extent of improvement score as they were not taking the prod-
ucts on a regular basis. 
Slightly more than half (53%) of patients were consuming or had con-
sumed probiotics (Table 3). The most common probiotic was Activia. Fe-
male patients (P = 0.029) and those who had completed more education 
(P < 0.000) were more likely to consume probiotics than men or those with 
less education. 
Fewer patients (38%) had consumed prebiotics (Table 3). The percent-
age of patients who were consuming prebiotics may have been higher if 
more prebiotic products had been listed on the handout, as a wide variety 
of products contain prebiotics. The most common prebiotic products con-
sumed were Kashi Go Lean Crunch (Kashi Co.) (26% of all prebiotic prod-
ucts consumed), Skinny Cow (Weight Watchers International, Inc.) ice cream 
sandwiches (26%) and Ensure (Abbott Nutrition) with FOS (20%). Patients 
who had completed more years of education were more likely to consume 
prebiotics (P < 0.000) than those with less education. 
Television or radio most influenced probiotic consumption, with 57% 
of patients being influenced by these forms of media. Interestingly, dieti-
tians (10%) and the Internet (3%) did not have a large impact on probiotic 
consumption. Similarly, patients were influenced to consume prebiotics by 
television or radio (37%), although family or friends had the largest impact 
(51%). Dietitians (21%) and the Internet (1%) appeared to have a lesser im-
pact on prebiotic consumption. 
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Table 3. Medical center patient probiotic and prebiotic product consumption.
Probiotics  n  %(a)  Prebiotics  n  %(b)
Consumption practice    Consumption practice
 Ever consumed probiotics(c)  105  53   Ever consumed prebiotics(d)  76  38
 Currently consuming  83  42   Currently consuming  62  31
Product    Product
 Yogurt  113  72   Kashi Go Lean Crunch  32  26
  Activia  93  59   Skinny Cow ice cream sandwiches  32  26
  YoPlus Yoplait yogurt  16  10  Ensure with FOS  20  16
  GoodBelly yogurt  4  3   Luna bar  19  16
  Lowell Polish yogurt  1 1   South Beach Diet bars  16  13
 Dairy drink  31  20   Other  2  2
  DanActive dairy drink  16  10   Breakstones LiveActive cottage cheese  1  1
  Kefir  12  8 
  Activia dairy drink  1  1
  Other (unspecified)  1  1
 Pill  11  7
  Florajen  1  1
  Florastor  1  1
  Other (pills unspecified)  9  6
 Cereals  2  1
  Vive Kashi  2  1
Frequency of consumption    Frequency of consumption
 Once per day  7  5   Once per day  1  1
 Daily  63  40   Daily  30  25
 2–3 times per week  20  13   Weekly  33  27
 Weekly  8  5   Monthly  7  6
 Monthly  5  3  Infrequently/rarely  49  40
 Infrequently/rarely  54  34   As needed  2  2
Serving size    Serving size
 4 oz  126  80   1 each  62  51
 8 oz  14  9   2 each  9  7
 >8 oz  6  4   4 each  1  1
 1 pill  6  4   ≤1 cup  37  30
 2 pills  4  3   2 cups  10  8
 3 pills  1  1  3+ cups  3  3
(a) Percentage of total based on 157 responses.
(b) Percentage of total based on 122 responses.
(c) Significantly more females were consuming probiotics.
(d) Significant difference found based on education; highest education group had the highest percentage of 
consumption of prebiotics.
FSO, fructooligosaccharides.
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Discussion 
At the present time, there is a gap in the literature regarding probiotic and 
prebiotic knowledge, use and perceptions in a hospitalized patient pop-
ulation as previous studies have used a free-living population. For exam-
ple, a 2008 survey by the Research Opinion Corporation found that 85% of 
people interviewed reported knowing “little to nothing” about probiotics; 
a survey by Kraft foods found similar results revealing 63% of people inter-
viewed were not at all familiar with probiotics.25 In the current study, 57% 
of patients reported being unfamiliar with the term “probiotic” without any 
further explanation of the term after the definition was explained; 73% of 
patients interviewed were familiar with the concept of probiotics compared 
with only 15% found by the Research Opinion Corporation.25 The higher fa-
miliarity found in this study may be due to the fact that the questionnaire 
was completed 2 years after the previous study and the market and adver-
tising for probiotics has increased dramatically in recent years.26 Kraft foods 
found that only 13% of those familiar with probiotics could define them ac-
curately compared with 40% in the current study. This discrepancy may be 
due to differences in questionnaire design or population sampled (hospi-
talized vs free-living). 
A 2007 consumer attitudes survey in a free-living population found 37% 
of individuals were consuming probiotics for immune health and 41% for 
digestive health compared with 11% for immunity and 41% for digestion 
in the current study.27 The consumer attitudes survey found 37% of people 
were consuming prebiotics for digestion compared with 18% for digestion 
in the current study; however, 36% were consuming prebiotics for general 
gut health. In 2009, yoghurt was the most popular mode of administration 
of probiotics, consistent with the current study where most (66%) probiotic 
products consumed were a type of yoghurt.28 In 2009, a business analysis 
company (Datamonitor) reported that 14% of people interviewed thought 
that probiotic health claims were untrustworthy compared with 40% of pa-
tients responding with either “not at all” or “a little” when asked if health 
claims on probiotic packages can be trusted.26 
There are several strengths to this study. This study covered a wide range 
of questions to help understand probiotic and prebiotic knowledge use, and 
perceptions. New and novel information was gathered, such as perceived 
extent of improvement with probiotic and prebiotic intake by health con-
dition, frequency and serving size of consumption, factors influencing con-
sumption, and comparisons by demographic factors. It is valuable to assess 
these parameters in hospitalized patients as this specific population may 
differ from the general population because of the potential for their health 
status to encourage use of dietary means of improving health. Of note, no 
Betz  et  al .  in  Nutr i t ion &  D ietet ics  72  (2015 )      10
probiotic or prebiotic products were offered in the hospital setting; there-
fore, dietary intake in the hospital likely did not influence responses. 
Limitations to this study include a small sample size. Our sample was 
taken from two urban medical centers and therefore, results cannot be gen-
eralized to free-living populations outside of this geographical environment. 
This study likely does not offer a comprehensive description of probiotic and 
prebiotic consumption because of the limited number of products on the 
handouts used in the study. It is likely that this is especially true for prebiot-
ics because of the large variety of products containing prebiotics. The type 
of products (e.g. yoghurts, bars, dairy drinks) reported to be consumed may 
have also been influenced by the type of products on the handout. While we 
saw differences in probiotic and prebiotic knowledge and intake by educa-
tion level, our ability to compare these groups is limited because of the dif-
ferences in samples sizes between groups. In addition, information related 
to past medical history information was not collected; the health status of 
patients may have influenced whether patients consumed probiotics or pre-
biotics and for which health conditions they were consumed. 
In conclusion, this study demonstrated that many patients at two large, 
urban medical centers are consuming products containing probiotics and 
prebiotics despite not understanding the true meaning of these terms. Pro-
biotics are much better recognized by inpatients compared with prebiotics. 
Inpatients are consuming probiotics mostly for gastrointestinal concerns and 
prebiotics to help reduce overweight and obesity. In light of these findings, 
it is important that healthcare professionals, including dietitians, are aware 
of patient probiotic and prebiotic consumption. This consumption provides 
cause for dietitians to inquire about use and to provide patient education to 
ensure that both probiotics and prebiotics are being consumed safely and 
for health conditions supported by research. 
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